Clinical data | |
---|---|
License data | |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
ECHA InfoCard | 100.000.932 |
Chemical and physical data | |
Formula | C19H29NO |
Molar mass | 287.447 g·mol−1 |
3D model ( JSmol) | |
| |
|
Cycrimine (trade name Pagitane) is a central anticholinergic drug designed to reduce the levels of acetylcholine in the treatment of Parkinson's disease. Its mechanism of action is to bind to the muscarinic acetylcholine receptor M1. [1]